Abstract
What was initially a lung infection epidemic in the metropolitan area of Wuhan followed by a now contained extension to mainland China has now spread to all continents as a major pandemic with current hotspots in Europe and the USA. This minireview is an update of an earlier report on this novel coronavirus infection (Brüssow, 2020, Microb Biotech 13, 607). I am now summarizing the research literature published between end of February to mid-April 2020.
© 2020 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology.
MeSH terms
-
Animals
-
Antiviral Agents / administration & dosage
-
Betacoronavirus / classification
-
Betacoronavirus / genetics
-
Betacoronavirus / isolation & purification
-
Betacoronavirus / physiology*
-
COVID-19
-
China
-
Clinical Trials as Topic
-
Coronavirus Infections / diagnosis
-
Coronavirus Infections / drug therapy
-
Coronavirus Infections / mortality
-
Coronavirus Infections / virology*
-
Health Personnel
-
Humans
-
Pandemics
-
Personal Protective Equipment / supply & distribution
-
Pneumonia, Viral / diagnosis
-
Pneumonia, Viral / drug therapy
-
Pneumonia, Viral / mortality
-
Pneumonia, Viral / virology*
-
SARS-CoV-2
-
Telemedicine